Annual Total Liabilities
$2.43 M
-$6.12 M-71.60%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual total liabilities is $2.43 million, with the most recent change of -$6.12 million (-71.60%) on December 31, 2023.
- During the last 3 years, SPRY annual total liabilities has fallen by -$38.03 million (-94.00%).
- SPRY annual total liabilities is now -97.38% below its all-time high of $92.72 million, reached on December 31, 2021.
Performance
SPRY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$16.62 M
+$9.90 M+147.18%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly total liabilities is $16.62 million, with the most recent change of +$9.90 million (+147.18%) on September 30, 2024.
- Over the past year, SPRY quarterly total liabilities has increased by +$9.90 million (+147.18%).
- SPRY quarterly total liabilities is now -82.07% below its all-time high of $92.72 million, reached on December 1, 2021.
Performance
SPRY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SPRY Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.6% | +147.2% |
| 3 y3 years | -94.0% | +147.2% |
| 5 y5 years | -94.0% | +147.2% |
SPRY Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.4% | at low | -82.1% | +584.6% |
| 5 y | 5-year | -97.4% | at low | -82.1% | +584.6% |
| alltime | all time | -97.4% | at low | -82.1% | +584.6% |
ARS Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.62 M(+147.2%) |
| Jun 2024 | - | $6.72 M(+81.0%) |
| Mar 2024 | - | $3.71 M(+53.0%) |
| Dec 2023 | $2.43 M | $2.43 M(-78.5%) |
| Sep 2023 | - | $11.27 M(+10.5%) |
| Jun 2023 | - | $10.20 M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $10.04 M(+17.4%) |
| Dec 2022 | $8.55 M(-90.8%) | $8.55 M(-90.5%) |
| Jun 2022 | - | $90.08 M(-2.8%) |
| Dec 2021 | $92.72 M(+129.2%) | - |
| Dec 2021 | - | $92.72 M |
| Dec 2020 | $40.46 M | - |
FAQ
- What is ARS Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual total liabilities year-on-year change?
- What is ARS Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly total liabilities year-on-year change?
What is ARS Pharmaceuticals annual total liabilities?
The current annual total liabilities of SPRY is $2.43 M
What is the all time high annual total liabilities for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual total liabilities is $92.72 M
What is ARS Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, SPRY annual total liabilities has changed by -$6.12 M (-71.60%)
What is ARS Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of SPRY is $16.62 M
What is the all time high quarterly total liabilities for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly total liabilities is $92.72 M
What is ARS Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, SPRY quarterly total liabilities has changed by +$9.90 M (+147.18%)